The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Simashkova N.V.

Mental Health Research Center

Makushkin E.V.

Serbsky Federal Medical Research Center of Psychiatry and Narcology

Ivanov M.V.

Bekhterev National Medical Research Center for Psychiatry and Neurology

Balakireva E.E.

Mental Health Research Center

Kulikov A.V.

Mental Health Research Center

Koval-Zaytsev A.A.

Mental Health Research Center

Luss L.A.

Mental Health Research Center

Models of clinical and social management of patients with autism spectrum disorders

Authors:

Simashkova N.V., Makushkin E.V., Ivanov M.V., Balakireva E.E., Kulikov A.V., Koval-Zaytsev A.A., Luss L.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(6): 13‑20

DOI: 10.17116/jnevro202112106113

Read: 2934 times

Contact the author
Table of contents

MODELS OF CLINICAL AND SOCIAL MANAGEMENT OF PATIENTS WITH AUTISM SPECTRUM DISORDERS
MODELS OF CLINICAL AND SOCIAL MANAGEMENT OF PATIENTS WITH AUTISM SPECTRUM DISORDERS

To cite this article:

Simashkova NV, Makushkin EV, Ivanov MV, Balakireva EE, Kulikov AV, Koval-Zaytsev AA, Luss LA. Models of clinical and social management of patients with autism spectrum disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(6):13‑20. (In Russ.)
https://doi.org/10.17116/jnevro202112106113

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Reha­bilitation of persons with primary orga­nic mental diso­rders complicated by alco­holism in middle and elde­rly age. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):55-63
Evaluation of the effe­ctiveness of inte­nsive medi­cal reha­bilitation in MS patients through the prism of functional tests and serum neurofilaments. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):79-83
Approaches to medi­cal reha­bilitation of patients with post-stroke hemianopsia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):20-25
Factors of health formation in disa­bled children with congenital cleft lip and/or palate. Stomatology. 2025;(2):30-36
Indi­cators of regi­stration of audi­tory brainstem responses in children with autism spectrum diso­rder. Russian Bulletin of Otorhinolaryngology. 2025;(3):19-23
Rela­tionship of the professional characteristics and the orga­nization of the mid-level medi­cal personnel reha­bilitation depa­rtments acti­vity to the health psychophysical indi­cators of children with disa­bilities. Russian Journal of Preventive Medi­cine. 2025;(7):28-35
Arti­ficial inte­lligence in comprehensive reha­bilitation of people with disa­bilities. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(3):54-61
The role of perioperative reha­bilitation of patients in surgical treatment of pelvic and lower extremity bone tumors with endo­prosthesis. P.A. Herzen Journal of Onco­logy. 2025;(4):22-28
Burnout syndrome: prevention, treatment and reha­bilitation. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):61-68
The exoskeleton of the hand in modern habi­litation and reha­bilitation (analytical review). Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(3):53-61
Abstract:

OBJECTIVE

To develop clinical and social models and management routes for patients with autism spectrum disorders (ASD).

MATERIAL AND METHODS

A clinical follow-up study was performed for 254 patients, aged 4—17 years (average age 7.3 years), who represented the main forms of ASD. Psychopathological, clinical-follow-up, psychological and statistical methods were used.

RESULTS AND CONCLUSION

Five management models for patients with different forms of ASD are described; differentiation of routes for interagency monitoring of patients is proposed. The effectiveness of the integrated use of drug and non-drug therapeutic approaches for the management of patients with ASD in the clinical-age aspect is shown. Timely diagnosis of ASD makes it possible to develop differentiated routes of patient management within the framework of interdepartmental interaction and achieve positive results in the clinical and age aspect.

Keywords:

child psychiatry
autism spectrum disorders
rehabilitation
clinical-social models
interagency collaboration
child psychiatry
autism spectrum disorders
rehabilitation
clinical-social models
interagency collaboration

Authors:

Simashkova N.V.

Mental Health Research Center

Makushkin E.V.

Serbsky Federal Medical Research Center of Psychiatry and Narcology

Ivanov M.V.

Bekhterev National Medical Research Center for Psychiatry and Neurology

Balakireva E.E.

Mental Health Research Center

Kulikov A.V.

Mental Health Research Center

Koval-Zaytsev A.A.

Mental Health Research Center

Luss L.A.

Mental Health Research Center

Received:

16.07.2020

Accepted:

22.07.2020

Close metadata

References:

  1. Makushkin EV, Baybarina EN, Chumakova OV, Demcheva NK. Fundamental tasks and problems of a mental health care of children in Russia. Psychiatry (Moscow). 2015;4:5-11. (In Russ.).
  2. Mukaetova-Ladinska EB, Simashkova NV, Mukaetova MS, Ivanov MV, Boksha IS. Autism spectrum disorders in children and adults: the experience of reserches from different countries. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018;118(12):92-99. (In Russ.). https://doi.org/10.17116/jnevro201811812192
  3. Ivanov MV, Simashkova NV, Kozlovskaya GV, Makushkin EV. The epidemiologic study of the risk of autism spectrum disorders in children of 16—24 months in Russia, 2015—2016. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018;118(5):12-19. (In Russ.). https://doi.org/10.17116/jnevro20181185212
  4. Zvereva NV, Koval-Zaytsev AA. Cognitive dizontogenezis with autism spectrum disorders and endogenous mental disorders in children and adolescents. Vestnik Soveta Molodykh Uchenykh i Spetsialistov Chelyabinskoi Oblasti. 2016;4(2):12-18. (In Russ.).
  5. Simashkova NV, Klyushnik TP, Yakupova LP. Clinical and biological approaches to the diagnostics and substantiation of personalized therapy in patients with autism spectrum disorders. Psychiatry (Moscow). 2018;2(78):17-24. (In Russ.).
  6. Myers J, Chavez A, Hill AP, Zuckerman K, Fombonne E. Epidemiological Surveys of Autism Spectrum Disorders. In book: Autism and Pervasive Developmental Disorders, 3rd Edition. Ed. by Volkmar F.R. Publisher: Cambridge University Press; 2019. https://doi.org/10.1017/9781108297769.003
  7. Churkin AA, Martyushov AN. A practical guide to the use of ICD-10 in psychiatry and narcology. M.: Publisher: SSC CuSP them. V.P. Serbsky; 2010. (In Russ.).
  8. Howlin P, Magiati I. Autism spectrum disorder: outcomes in adulthood. Current Opinion in Psychiatry. 2017;30(2):69-76.  https://doi.org/10.1097/yco.0000000000000308
  9. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Association. 2013. Data access: 02.04.20.  https://www.psychiatry.org/psychiatrists/practice/dsm
  10. Dedov II, Tyul’pakov AN, Chekhonin VP, Baklushev VP, Archakov AI, Moshkovskiĭ SA. Personalized medicine: state-of-the-art and prospects. Annals of the Russian Academy of Medical Sciences. 2012;67(12):4-12. (In Russ.). https://doi.org/10.15690/vramn.v67i12.474
  11. Bebchuk MA. The family of a mentally ill child, as part of a multi-professional team. Interdisciplinary approaches to the study of mental health of a person and society materials of a scientific and practical conference. M. 2019;415-419. (In Russ.).
  12. Tyushkevich SA, Pereverzeva DS, Mamokhina WA, Danilina KK, Salimova KR, Gorbachevskaya NL. Recommendations for the comprehensive support of families raising children with syndromic forms of ASD. Syndrome of mental retardation linked to fragile chromosome X. Methodical recommendations. Under the general. ed. Haustova A.V. M.: Publisher: FRC Federal State Budgetary Educational Institution of Higher Education at Moscow State Pedagogical University; 2018. (In Russ.).
  13. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen Bert E, van Ommen G-J, Bionden LAJ, Riggins GJ, Chastain JL, Kunst CB, Gaijaard H, Caskey T, Nelson DL, Oostra BA, Warren ST. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65(5):905-914.  https://doi.org/10.1016/0092-8674(91)90397-h
  14. Avrutsky GYa, Neduva AA. Treatment of mental patients. Guidelines. M.: Publisher: Medicine; 1981. (In Russ.).
  15. Drugs During Pregnancy and Lactation. Treatment Options and Risk Assessment, 3rd Edition. Edited by: Schaefer C., Peters P., Miller R.K. 2015.
  16. Snoek A, James P, Arenas-López S., Durward A. Levomepromazine for difficult sedation in pediatric intensive care. Journal of Pediatric Intensive Care. 2014;3(2):53-57.  https://doi.org/10.3233/pic-14089
  17. Angley M, Young R, Ellis D, Chan W, McKinnon R. Children and autism — Part 1 — recognition and pharmacological management. Australian Family Physician. 2007;36(9):741-744. 
  18. Stahl SM. Prescriber’s Guide. Children and Adolescents. UK. Publisher: Cambridge University; 2019.
  19. Proselkova ME, Uzhanov NV. Experience with using etaperazine (perphenazine) in the treatment of patients with schizophrenia in a preschool psychiatric department. Zhurnal Nevropatologii i Psikhiatrii im. S.S. Korsakova. 1991;91(1):120-122. (In Russ.).
  20. Banaschewski T, Poustka L, Holtmann M. Autism and ADHD across the life span. Differential diagnoses or comordidity? Nervenarzt. 2011;82(5):573-580.  https://doi.org/10.1007/s00115-010-3239-6
  21. Simashkova NV. Effective pharmacotherapy and rehabilitation of patients with autism spectrum disorders. Effective Pharmacotherapy. Neurology and Psychiatry. 2011;3:14-22. (In Russ.).
  22. The electronic collection of drugs — EMC: Periciazine. Data access: 02.04.20.  https://www.medicines.org.uk/emc/product/3962/smpc
  23. Findling RL, Steiner H, Weller EB. Use of antipsychotics in children and adolescents. Journal of Clinical Psychiatry. 2005;66(suppl 7):29-40. 
  24. Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. Journal of Autism and Developmental Disorders. 1989;19(2):227-239.  https://doi.org/10.1007/bf02211843
  25. Chabrol H, Bonnet D, Roge B. Psychopharmacologie de l’autisme [Psychopharmacology of autism]. Encephale. 1996;22(3):197-203. 
  26. Beherec L, Lambrey S, Quilici G, Rosier A, Falissard B, Guillin O. Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors. Journal of Clinical Psychopharmacology. 2011;31(3):341-344.  https://doi.org/10.1097/jcp.0b013e318218f4a1
  27. Gobbi G, Pulvirenti L. Long-term treatment with clozapine in an adult with autistic disorder and severe disruptive behaviors. Journal of Clinical Psychopharmacology. 2001;26(4):340-341. 
  28. Wink LK, Badran I, Pedapati EV, Sorensen R, Benton SC, Johnson MC, Wissel G, Erickson CA. Clozapine for drug-refractory irritability in individuals with developmental disability. Journal of Child and Adolescent Psychopharmacology. 2016;26(9):843-846.  https://doi.org/10.1089/cap.2015.0216
  29. Rothenberger A. Psychopharmacological treatment of self-injurious behavior in individuals with autism. Acta Paedopsychiatr. 1993;56(2):99-104. 
  30. Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 2015;25(6):482-493.  https://doi.org/10.1089%2Fcap.2015.0005
  31. Elbe D, Lalani Z. Review of the pharmacotherapy of irritability of autism. Journal of the Canadian Academy of Child and Adolescent Psychiatry. 2012;21(2):130-146. 
  32. Hirsch LE, Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews. 2016;6. Art. No.: CD009043. https://doi.org/10.1002/14651858.CD009043.pub3
  33. Ichikawa H, Mikami K, Okada T, Yamashita Y, Ishizaki Y, Tomoda A, Ono H, Usuki C, Tadori Y. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Child Psychiatry and Human Development. 2017;48(5):796-806.  https://doi.org/10.1007/s10578-016-0704-x
  34. Caccia S. Safety and Pharmacokinetics of Atypical Antipsychotics in Children and Adolescents. Paediatric Drugs. 2013;15(3):217-233.  https://doi.org/10.1007/s40272-013-0024-6
  35. Sharma A, Shaw SR. Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis. Journal of Pediatric Health Care. 2012;26(4):291-299.  https://doi.org/10.1016/j.pedhc.2011.02.008
  36. Hellings JA, Arnold LE, Han JC. Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline. Expert Opin Pharmacother. 2017;18(6):581-588.  https://doi.org/10.1080/14656566.2017.1308483
  37. Potter LA, Scholze DA, Biag HMB, Schneider A, Chen Y, Nguyen DV, Rajaratnam A, Rivera SM, Dwyer PS, Tassone F, Al Olaby RR, Choudhary NS, Salcedo-Arellano MJ, Hagerman RJ. A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder. Frontiers in Psychiatry. 2019;10:810.  https://doi.org/10.3389/fpsyt.2019.00810
  38. Ibragimov DF. Alimemazin in medical practice. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2008;9(108):76-78. (In Russ.).
  39. Bykov YuV, Bekker RA. Hopantenic acid: perspectives for its use in psychiatry. Consilium Medicum. 2018;20(2):112-123. (In Russ.).
  40. Kalinina MA, Kozlovskaya GV, Kremneva LF. Levocarnitine in pediatric practice. RMJ. Medical Review. 2018;10:40-44. (In Russ.).
  41. García-Carmona JA, Simal-Aguado J, Campos-Navarro MP, Valdivia-Muñoz F, Galindo-Tovar A. Long Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real World Study. Clinical Drug Investigation. 2020;40:459-468.  https://doi.org/10.1007/s40261-020-00913-7
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.